首页> 美国卫生研究院文献>Nutrition Diabetes >Reduced expression of stearoyl-CoA desaturase-1 but not free fatty acid receptor 2 or 4 in subcutaneous adipose tissue of patients with newly diagnosed type 2 diabetes mellitus
【2h】

Reduced expression of stearoyl-CoA desaturase-1 but not free fatty acid receptor 2 or 4 in subcutaneous adipose tissue of patients with newly diagnosed type 2 diabetes mellitus

机译:新诊断2型糖尿病患者皮下脂肪组织中硬脂酰辅酶A去饱和酶-1表达降低但游离脂肪酸受体2或4表达降低

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIn subcutaneous adipose tissue (SAT), higher stearoyl-CoA desaturase-1 (SCD1) expression has been related to improved insulin sensitivity in thiazolidinedione-treated type 2 diabetes mellitus patients. In animal models, deficiency of the free fatty acid receptor (FFAR) 2 associated with higher and FFAR4-deficiency with lower insulin sensitivity. We hypothesized that increased FFAR2 expression and reductions in FFAR4 and SCD1 expression in SAT of type 2 diabetes mellitus patients associate positively with insulin resistance and impaired beta cell function.
机译:背景在皮下脂肪组织(SAT)中,较高的硬脂酰辅酶A去饱和酶1(SCD1)表达与噻唑烷二酮治疗的2型糖尿病患者的胰岛素敏感性改善有关。在动物模型中,游离脂肪酸受体(FFAR)2的缺乏与较高和FFAR4的缺乏以及较低的胰岛素敏感性有关。我们假设2型糖尿病患者的SAT中FFAR2表达的增加和FFAR4和SCD1表达的减少与胰岛素抵抗和β细胞功能受损呈正相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号